Post Resch Tallon Group Inc. Zomedica Corp. Transaction History
Post Resch Tallon Group Inc.
- $104 Billion
- Q4 2024
A detailed history of Post Resch Tallon Group Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 150,000 shares of ZOM stock, worth $18,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$18,000% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ZOM
# of Institutions
87Shares Held
81.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$5.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.93MShares$1.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.18 Million0.0% of portfolio
-
State Street Corp Boston, MA3.51MShares$421,1850.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$295,9830.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $118M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...